Insulet Corporation (PODD)

174,43 +1,01 (+0,58%) Al cierre: 04:00PM EDT

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 3000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. James R. Hollingshead Ph.D.	President, CEO & Director	2,88M	N/A	1963
Ms. Lauren Budden	Group VP, Chief Accounting Officer & Controller	794,05k	N/A	1975
Mr. Mark Field	Senior VP & CTO	954,14k	N/A	1971
Mr. John Wodick Kapples	Senior VP & General Counsel	1,02M	N/A	1960
Ms. Shacey Petrovic	Director & Advisor	28,57k	N/A	1973
Mr. Eric Benjamin	Executive VP, Chief Product & Customer Experience Officer	1,14M	N/A	1983
Ms. Ana Maria Chadwick	Executive VP, CFO & Treasurer	N/A	N/A	1972
Mr. Prem Singh	Senior Vice President of Global Operations	N/A	N/A	1977
Ms. Deborah R. Gordon CPA	Vice President of Investor Relations	N/A	N/A	1971
Ms. Laetitia Cousin	Senior VP of Regulatory Affairs, Quality Assurance & Compliance	N/A	N/A	1976

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Insulet Corporation, a día 1 de mayo de 2024, es 9. Las puntuaciones base son Auditoría: 7; Tablero: 8; Derechos de los accionistas: 10; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.